Dedicated to helping people with life-threatening conditions through scientific innovations and excellence
Inhibrx develops multivalent costimulatory agonists, checkpoint inhibitors, and therapeutics to invert the tumor microenvironment toward local immune activation.
Challenges
Difficulty finding data across multiple systems | Without a formal tracking system, plasmid maps were distributed across multiple scientists’ computers. Finding the right plasmid map would involve walking through the lab to find the right scientist. |
---|---|
Lack of data integrity | Spreadsheets were used to track requests and information about plasmids, requiring extensive manual search and limiting user compliance. |
Tracking processes with paper | Experimental notes were taken using a shared paper lab notebook, making it difficult to find experimental details and extract insights. |
Outcomes
Reliable registration | The Benchling Registry is a central source of truth for plasmids and enforces uniqueness constraints to ensure data integrity. |
---|---|
Interlinked experimental details | Scientists can link batches to relevant experiments, so their notes directly reflect all of the products and data they’ve generated. |
Streamlined IND filing | Inhibrx uses Benchling Lab Notebook entries and unique Lab Notebook IDs to file for IND, saving months of time and effort. |
Powering breakthroughs for over 1,300 biotechnology companies, from startups to Fortune 500s